Be it enacted by the General Assembly of Virginia:

1. §1. That the Secretary of Health and Human Resources (the Secretary), in collaboration with the Department of Health, shall convene a work group to analyze and review current reimbursement and operational challenges for medical practices that administer anti-cancer drugs in an in-office setting to patients whose costs for such treatment are paid for by Medicare, Medicaid, or TRICARE. The analysis shall consider the impact on and accessibility of such treatment for Medicaid, Medicare, and TRICARE patients. The work group shall include relevant stakeholders, including representatives from the Medical Society of Virginia, the Virginia Association of Hematologists and Oncologists, the Virginia Association of Counties, and the Virginia Municipal League. Assistance shall be provided to the work group by the Department of Medical Assistance Services. The work group shall complete its meetings by October 1, 2023, and submit a report of its findings and recommendations to the Chairmen of the House Committee on Finance, the House Committee on Appropriations, the House Committee on Health, Welfare and Institutions, the Senate Committee on Finance and Appropriations, and the Senate Committee on Education and Health by November 15, 2023.